Current Medicinal Chemistry

Preface [Hot Topic: Advances in the Studies of Anti-HIV Drugs-Part I (Guest Editor: S.P. Gupta)]
pp. i-i(1)
Author: Gupta S. P.

Virus Entry as a Target for Anti-HIV Intervention
pp. 1617-1632(16)
Author: Este Jose A.

Inhibiting HIV-1 Entry with Fusion Inhibitors
pp. 1633-1642(10)
Authors: Baldwin C. E.; Sanders R. W.; Berkhout B.

Hybrid Canonical-Correlation Neural-Network Approach Applied to Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors (HEPT Derivatives)
pp. 1643-1659(17)
Author: Mager Peter P.

Hologram Quantitative Structure-Activity Relationships Investigations of Non-nucleoside Reverse Transcriptase Inhibitors
pp. 1661-1677(17)
Authors: Pungpo Pornpan; Hannongbua Supa; Wolschann Peter

HIV-1 Protease Inhibitors: A Comparative QSAR Analysis
pp. 1679-1688(10)
Authors: Kurup Alka; Mekapati Suresh B.; Garg Rajni; Hansch Corwin

Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDS
pp. 1689-1695(7)
Authors: Sriram Dharmarajan; Yogeeswari Perumal

Combretastatin A-4 Analogues as Antimitotic Antitumor Agents
pp. 1697-1722(26)
Author: Nam Nguyen-Hai

The Isoprostanes: Unique Products of Arachidonic Acid Oxidation-A Review
pp. 1723-1740(18)
Authors: Fam Samuel S.; Morrow Jason D.

Design of -Lactams with Mechanism Based Nonantibacterial Activities
pp. 1741-1757(17)
Authors: Veinberg Grigory; Vorona Maxim; Shestakova Irina; Kanepe Iveta; Lukevics Edmunds

A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase
pp. 1759-1764(6)
Authors: Inoguchi T.; Tsubouchi H.; Etoh T.; Kakimoto M.; Sonta T.; Utsumi H.; Sumimoto H.; Yu H. Y.; Sonoda N.; Inuo M.; Sato N.; Sekiguchi N.; Kobayashi K.; Nawata H.